Patents Assigned to Arthrogen B.V.
  • Patent number: 9943574
    Abstract: The invention provides a combination of a source of a CD39 and of a source of a CD73.
    Type: Grant
    Filed: June 26, 2013
    Date of Patent: April 17, 2018
    Assignee: Arthrogen B.V.
    Inventor: Jonathan D. Finn
  • Publication number: 20150190481
    Abstract: The invention provides a combination of a source of a CD39 and of a source of a CD73.
    Type: Application
    Filed: June 26, 2013
    Publication date: July 9, 2015
    Applicant: Arthrogen B.V.
    Inventor: Jonathan D. Finn